68 related articles for article (PubMed ID: 7756738)
1. Human IgA nephritis: immunocytochemical evidence of a chronic inflammatory proliferative disorder.
Yoshioka K; Maki S
Histol Histopathol; 1995 Jan; 10(1):203-12. PubMed ID: 7756738
[TBL] [Abstract][Full Text] [Related]
2. Regulatory mechanism in glomerular mesangial cell proliferation.
Haas CS; Schöcklmann HO; Lang S; Kralewski M; Sterzel RB
J Nephrol; 1999; 12(6):405-15. PubMed ID: 10626832
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
4. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
[TBL] [Abstract][Full Text] [Related]
5. [Role of tumor necrosis alpha in the regulation of extracellular matrix and proliferation of mesangial cells in nephrotoxic nephritis].
Ivanov AA; Gladskikh OP; Bogomazova SIu; Opalenov KV; Shilov EM; Pal'tsev MA
Arkh Patol; 1998; 60(1):27-30. PubMed ID: 9582985
[TBL] [Abstract][Full Text] [Related]
6. A quantitative study of mesangial deposits and glomerular monocytes/macrophages in IgA-nephropathy and proliferative mesangial (non-IgA) glomerulonephritis.
Danilewicz M; Wagrowska-Danilewicz M
J Nephrol; 1998; 11(5):255-60. PubMed ID: 9831239
[TBL] [Abstract][Full Text] [Related]
7. Morphological features in IgA nephropathy.
Ferrario F; Rastaldi MP; Napodano P
Ann Med Interne (Paris); 1999 Feb; 150(2):108-16. PubMed ID: 10392259
[TBL] [Abstract][Full Text] [Related]
8. Cytokines and mesangial cells.
Sterzel RB; Schulze-Lohoff E; Marx M
Kidney Int Suppl; 1993 Jan; 39():S26-31. PubMed ID: 8468921
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells.
Daniel C; Duffield J; Brunner T; Steinmann-Niggli K; Lods N; Marti HP
J Pharmacol Exp Ther; 2001 Apr; 297(1):57-68. PubMed ID: 11259528
[TBL] [Abstract][Full Text] [Related]
10. Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation?
Eng E; Floege J; Young BA; Couser WG; Johnson RJ
Kidney Int Suppl; 1994 Feb; 45():S45-7. PubMed ID: 8158896
[No Abstract] [Full Text] [Related]
11. Mesangial autoantigens in IgA nephropathy: matrix synthesis and localization.
Darvill AM; Ballardie FW
J Lab Clin Med; 2006 Jun; 147(6):301-9. PubMed ID: 16750668
[TBL] [Abstract][Full Text] [Related]
12. Mesangial cell Fas ligand: upregulation in human lupus nephritis and NF-kappaB-mediated expression in cultured human mesangial cells.
Tsukinoki T; Sugiyama H; Sunami R; Kobayashi M; Onoda T; Maeshima Y; Yamasaki Y; Makino H
Clin Exp Nephrol; 2004 Sep; 8(3):196-205. PubMed ID: 15480896
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and extracellular matrix-cell interactions in kidney disease.
Makino H; Sugiyama H; Kashihara N
Kidney Int Suppl; 2000 Sep; 77():S67-75. PubMed ID: 10997693
[TBL] [Abstract][Full Text] [Related]
14. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo.
Floege J; Eng E; Young BA; Johnson RJ
Kidney Int Suppl; 1993 Jan; 39():S47-54. PubMed ID: 8468926
[TBL] [Abstract][Full Text] [Related]
15. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation.
Gómez-Guerrero C; López-Armada MJ; González E; Egido J
J Immunol; 1994 Dec; 153(11):5247-55. PubMed ID: 7963578
[TBL] [Abstract][Full Text] [Related]
16. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation.
Kamanna VS; Pai R; Roh DD; Kirschenbaum MA
Lab Invest; 1996 Jun; 74(6):1067-79. PubMed ID: 8667611
[TBL] [Abstract][Full Text] [Related]
17. Proto-oncogene expression in human glomerular diseases.
Takemura T; Okada M; Akano N; Murakami K; Hino S; Yagi K; Takekoshi Y; Yoshioka K
J Pathol; 1996 Mar; 178(3):343-51. PubMed ID: 8778342
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
19. New strategy to treat glomerular inflammation by inhibition of mesangial cell matrix metalloproteinases.
Marti HP
Schweiz Med Wochenschr; 2000 May; 130(21):784-8. PubMed ID: 10904987
[TBL] [Abstract][Full Text] [Related]
20. [Mesangium: interactions between mesangial cells and extracellular matrix].
Ivić M; Bogićević M; Stefanović V
Srp Arh Celok Lek; 1994; 122(3-4):96-8. PubMed ID: 17972820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
